Yüklüyor......
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but not after Medical Management in Patients with Type 2 Diabetes
PURPOSE: To quantify changes in fibroblast growth factor 19 (FGF19) and bile acids (BAs) in patients with uncontrolled type 2 diabetes randomized to Roux-en-Y gastric bypass (RYGB) vs intensive medical management (IMM) and matched for similar reduction in HbA1c after 1 year of treatment. MATERIALS A...
Kaydedildi:
| Yayımlandı: | Obes Surg |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4751075/ https://ncbi.nlm.nih.gov/pubmed/26259981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11695-015-1834-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|